Drug Channels

MARCH 5, 2024

The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. This event is part of The Drug Channels 2024 Video Webinar Series. The potential effect of the IRA on manufacturers’ new drug research and development strategies is beyond the scope of this webinar.

Pharmacy 98

Pharmacy Biosimilars Drugs Marketing 98

Agency IQ

JUNE 9, 2023

Here, we’re starting some deeper analysis of aspects of the proposal package with a look at the impact of orphan drug provisions, seeing what impact the new provisions and the surrounding uncertainty might have on innovation. Other orphan drugs, which, by definition, address an unmet medical need, “only” receive 9 years of market exclusivity.

Marketing 40

Marketing Regulations Biosimilars Drugs 40

Agency IQ

AUGUST 2, 2024

By Sebastian Godoy, MPH , Kirsten Messmer, PhD, RAC, Corey Jaseph, MS, RAC , Kari Oakes | Oct 25, 2023 5:20 PM CDT | Updated Jul 31, 2024 10:17 PM CDT What we expect to be talking about in August and September Based on our scanning, AgencyIQ expects that August will be another sleepy summer month for European regulators. (ACT

Regulations 40

Regulations Clinical Trials Production Trials 40